Research Programs


Research Interests

Multiple sclerosis (MS), MRI biomarkers with clinical utility in prognostication and disease monitoring, cohort studies

Research Activities

Jiwon Oh is a staff neurologist, scientist, and Medical Director of the Barlo Multiple Sclerosis (MS) Program at St. Michael’s Hospital, University of Toronto. Dr. Oh’s research focuses on developing advanced MRI techniques in the spinal cord and brain for use in clinical settings. She leads the MRI research program at St. Michael’s Hospital, and is the principal investigator on numerous local and multi-center collaborative studies, including the Canadian Prospective Cohort Study to Understand Progression in MS (CanProCo), which is a national prospective cohort study designed to better understand progression in MS.

Recent Publications

  1. Solomon, JM, Jones, A, Hohol, M, Krysko, KM, Muccilli, A, Roll, A et al.. Clinical characteristics and outcomes of multiple sclerosis patients with COVID-19 in Toronto, Canada. Mult Scler Relat Disord. 2022;58 :103509. doi: 10.1016/j.msard.2022.103509. PubMed PMID:35030366 PubMed Central PMC8741626.
  2. Yang, Z, Pou-Prom, C, Jones, A, Banning, M, Dai, D, Mamdani, M et al.. Assessment of Natural Language Processing Methods for Ascertaining the Expanded Disability Status Scale Score From the Electronic Health Records of Patients With Multiple Sclerosis: Algorithm Development and Validation Study. JMIR Med Inform. 2022;10 (1):e25157. doi: 10.2196/25157. PubMed PMID:35019849 .
  3. Oh, J, Walker, B, Giovannoni, G, Jack, D, Dangond, F, Nolting, A et al.. Side effects that occurred early in people with multiple sclerosis during the first year of treatment with cladribine tablets: a plain language summary. Neurodegener Dis Manag. 2022; :. doi: 10.2217/nmt-2021-0041. PubMed PMID:35019731 .
  4. Fauchon, C, Kim, JA, El-Sayed, R, Osborne, NR, Rogachov, A, Cheng, JC et al.. Exploring sex differences in alpha brain activity as a potential neuromarker associated with neuropathic pain. Pain. 2021; :. doi: 10.1097/j.pain.0000000000002491. PubMed PMID:34711764 .
  5. Oh, J, Arbour, N, Giuliani, F, Guenette, M, Kolind, S, Lynd, L et al.. The Canadian prospective cohort study to understand progression in multiple sclerosis (CanProCo): rationale, aims, and study design. BMC Neurol. 2021;21 (1):418. doi: 10.1186/s12883-021-02447-7. PubMed PMID:34706670 PubMed Central PMC8549411.
  6. Oh, J, Vukusic, S, Tiel-Wilck, K, Inshasi, JS, Rog, D, Baker, DP et al.. Efficacy and Safety of Teriflunomide in Multiple Sclerosis across Age Groups: Analysis from Pooled Pivotal and Real-world Studies. J Cent Nerv Syst Dis. 2021;13 :11795735211028781. doi: 10.1177/11795735211028781. PubMed PMID:34377047 PubMed Central PMC8330455.
  7. Oh, J, Walker, B, Giovannoni, G, Jack, D, Dangond, F, Nolting, A et al.. Treatment-emergent adverse events occurring early in the treatment course of cladribine tablets in two phase 3 trials in multiple sclerosis. Mult Scler J Exp Transl Clin. ;7 (3):20552173211024298. doi: 10.1177/20552173211024298. PubMed PMID:34345436 PubMed Central PMC8283088.
  8. Bittner, S, Oh, J, Havrdová, EK, Tintoré, M, Zipp, F. The potential of serum neurofilament as biomarker for multiple sclerosis. Brain. 2021;144 (10):2954-2963. doi: 10.1093/brain/awab241. PubMed PMID:34180982 PubMed Central PMC8634125.
  9. Reyes, S, Cunningham, AL, Kalincik, T, Havrdová, EK, Isobe, N, Pakpoor, J et al.. Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement. J Neuroimmunol. 2021;357 :577627. doi: 10.1016/j.jneuroim.2021.577627. PubMed PMID:34139567 PubMed Central PMC8183006.
  10. Wattjes, MP, Ciccarelli, O, Reich, DS, Banwell, B, de Stefano, N, Enzinger, C et al.. 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. Lancet Neurol. 2021;20 (8):653-670. doi: 10.1016/S1474-4422(21)00095-8. PubMed PMID:34139157 .
Search PubMed

Affiliations & Other Activities

  • Staff Neurologist, Division of Neurology, Department of Medicine, St. Michael’s Hospital
  • Associate Professor, Department of Medicine, University of Toronto
  • Adjunct Faculty, Department of Neurology, Johns Hopkins University